Quigley Insulag Refractory Cement

Product Description

Quigley Insulag Refractory Cement was a high-temperature insulating and bonding cement manufactured by the Quigley Company, a New York-based firm that specialized in refractory and furnace products throughout much of the twentieth century. Insulag was formulated for use in industrial settings where extreme heat resistance was required, including the lining, patching, and sealing of furnaces, kilns, boilers, and other high-temperature equipment. The product was marketed primarily to industrial facilities and was used extensively in steel mills, foundries, chemical plants, power generation facilities, and other heavy manufacturing environments.

Quigley Company produced Insulag Refractory Cement from approximately 1935 through 1974, a period that coincided with widespread industrial reliance on asbestos as a binding and insulating additive in refractory compounds. The product was sold in bulk quantities and applied by workers who mixed, troweled, and packed the cement into the joints and linings of high-heat equipment. During its years of production, Insulag was considered an effective solution for maintaining the integrity of refractory installations under sustained thermal stress.

The Quigley Company was eventually acquired, and its product lines and associated liabilities became the subject of significant asbestos litigation as the health consequences of chrysotile asbestos exposure became better understood and legally actionable in the latter decades of the twentieth century.


Asbestos Content

Quigley Insulag Refractory Cement contained chrysotile asbestos, the most commercially used form of asbestos throughout the twentieth century. Chrysotile, sometimes referred to as white asbestos, is a serpentine mineral fiber that was valued in refractory products for its ability to bind materials together while withstanding high temperatures without degrading. In refractory cement applications, chrysotile fibers were integrated into the product’s matrix to enhance tensile strength, reduce thermal cracking, and improve overall durability under cyclical heating and cooling conditions.

Despite its widespread commercial use, chrysotile asbestos is classified as a known human carcinogen by the International Agency for Research on Cancer (IARC) and is regulated as a hazardous material under the Occupational Safety and Health Administration (OSHA) and the Asbestos Hazard Emergency Response Act (AHERA). The incorporation of chrysotile into refractory cements like Insulag meant that workers who handled, mixed, applied, or disturbed the hardened product were potentially exposed to respirable asbestos fibers throughout the product’s years of manufacture and use.

Litigation records document that the Quigley Company was aware of questions surrounding asbestos safety during the latter portion of Insulag’s production run, and plaintiffs alleged that the company failed to provide adequate warnings about the hazards associated with exposure to the product’s asbestos content.


How Workers Were Exposed

Industrial workers across a range of trades and settings were potentially exposed to asbestos fibers released during the handling and application of Quigley Insulag Refractory Cement. Exposure pathways were varied and depended on the specific tasks being performed, the condition of the product, and the ventilation characteristics of the work environment.

Mixing and preparation represented one of the primary exposure scenarios. Workers who opened bags of dry refractory cement and mixed the material with water to achieve workable consistency were subject to direct inhalation of airborne asbestos dust generated during the blending process. Dry mixing in enclosed or poorly ventilated spaces such as furnace rooms or maintenance areas could produce significant concentrations of respirable fiber.

Application and troweling created ongoing exposure as workers packed, spread, and shaped the cement into furnace linings, boiler joints, and kiln walls. Physical manipulation of the wet or partially dried cement could release fibers, and any splashing or scraping during application added to the overall dust burden in the immediate work area.

Demolition and repair work posed additional risks. When existing Insulag-lined surfaces were broken apart, chipped, or removed to allow for furnace relining or equipment maintenance, the hardened cement was subject to mechanical disturbance that could release previously bound asbestos fibers in concentrated form. Workers performing maintenance on lined equipment without respiratory protection were potentially exposed to elevated fiber levels during these activities.

Bystander exposure was also a documented concern in industrial environments. Workers in adjacent areas of a facility who were not directly handling Insulag could nonetheless inhale fibers carried through shared air spaces, particularly in older industrial buildings without modern ventilation systems.

Litigation records document that plaintiffs who worked in steel mills, foundries, power plants, and related industrial settings alleged significant and prolonged exposure to asbestos-containing refractory products including Insulag. Plaintiffs alleged that Quigley Company failed to warn workers of the respiratory hazards associated with the product, did not provide instructions for safe handling, and did not include cautionary labeling during a period when industrial hygiene standards for asbestos were actively being discussed within the industry.

Diseases associated with occupational asbestos exposure, including mesothelioma, asbestosis, and lung cancer, have been diagnosed among workers with documented histories of contact with refractory cement products containing chrysotile asbestos.


Unlike many asbestos manufacturers of the same era, the Quigley Company does not have an established and independently operating asbestos bankruptcy trust fund available to process claims under standard trust claim procedures. Quigley filed for bankruptcy protection in the early 2000s as asbestos-related liabilities mounted, and the resulting legal proceedings involved complex litigation over successor liability and insurance coverage rather than the creation of a straightforward claimant trust of the type established under Section 524(g) of the U.S. Bankruptcy Code.

As a result, individuals who were exposed to Quigley Insulag Refractory Cement and subsequently developed asbestos-related diseases must pursue compensation through civil litigation rather than through an administrative trust claim process. Litigation records document that mesothelioma and other asbestos disease cases involving Quigley products have been filed in multiple jurisdictions, with plaintiffs alleging negligence, failure to warn, strict products liability, and related claims.

Individuals who may have legal options include:

  • Industrial workers who mixed, applied, or disturbed Insulag Refractory Cement between approximately 1935 and 1974
  • Workers in furnace maintenance, boiler repair, foundry operations, or related trades with documented or recalled contact with Quigley refractory products
  • Family members of workers who may have experienced secondary exposure through contaminated work clothing

Because no trust fund exists for streamlined administrative claims, the litigation process typically requires the assistance of an attorney experienced in asbestos personal injury law. Such attorneys can evaluate employment history, medical records, and exposure documentation to identify viable legal pathways, which may also include claims against other solvent defendants or existing asbestos trusts if multiple products were involved in a claimant’s exposure history.

Statutes of limitations for asbestos claims vary by state and generally begin to run from the date of diagnosis rather than the date of exposure. Individuals diagnosed with mesothelioma, asbestosis, or asbestos-related lung cancer who have a history of industrial work involving refractory products should consult qualified legal counsel promptly to preserve their rights.